Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
Institute For Ayurved Studies And Research, Umri road, sector 8, Kurukshetra
Eligibility
Inclusion criteria
Inclusion criteria: Randomly selected irrespective of their caste, religion and sex. Non-Alcoholic i.e.Total abstainer of alcoholic intake. USG confirmed Grade I or Grade II fatty liver. The patients with signs and symptoms of NAFLD, Yakritroga are mentioned in the text. The ratio of AST and ALT less than 2 NAFLD diagnosed patients confirmed by USG with or without symptoms like anorexia, fatigue, and abdominal discomfort. Both freshly diagnosed and previously diagnosed cases of NAFLD. Voluntary assigned and enrolment of participants in the study.
Exclusion criteria
Exclusion criteria: USG showing grade III fatty liver. AST and ALT ratio greater than 2 Presence of any other identified cause of liver disease Portal hypertension, Ascites, viral hepatitis, Liver parenchymal disease, HCC, Wilson disease, Cirrhosis or any other conditions interfering with the result of the treatment of NAFLD. Individuals on any anticoagulants. history of Cardiac Arrhythmia, MI, Acute coronary syndrome, Stroke Syndrome, and other cardiac symptoms, Severe within the last 6 months, and comorbidities. Patient with Symptomatic congestive cardiac failure. Uncontrolled pulmonary function, Diabetes Mellitus, chronic kidney disease other severe and chronic diseases. Serum creatinine greater than 1.2mg per dl. Malignancies, HIV, TB, other infectious diseases pregnancy and lactating women Taking Corticosteroids and antidepressants, anti cholinergic, hepatotoxic medications or any other drugs for more than 6 weeks that influences the outcome of the study. Alcoholics and any other drug abusers. Patient has a history of hypersensitivity to the trial drug or any of its ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This will be assessed based on the improvement in ALT level in the patients of NAFLDTimepoint: 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| This will be assessed based on improvement in subjective parameters and other test parameters i.e. AST level, Alkaline Phosphate, serum cholesterol and serum triglyceride in the patients of NAFLD.Timepoint: 60 days | — |
Countries
India
Contacts
Public ContactDr Neha Lamba
INSTITUTE FOR AYURVED STUDIES AND RESEARCH
Outcome results
None listed